Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4726 to 4740 of 8221 results

  1. What is the most clinically and cost-effective dual antiplatelet therapy for people aged 75 and over with an acute coronary syndrome, who are having percutaneous coronary intervention (PCI)?

    Recommendation ID NG185/1 Question What is the most clinically and cost-effective dual antiplatelet therapy for people aged 75 and over

    Research recommendation
    Published
    22 January 2021

  2. In patients with negative MRI (Likert score 1 or 2), what is the next best diagnostic investigation to rule out clinically significant prostate cancer? What is the diagnostic accuracy of transperineal mapping biopsy compared with transperineal non-mapping biopsy in the diagnosis of clinically significant prostate cancer?

    Recommendation ID NG131/7 Question In patients with negative MRI (Likert score 1 or 2), what is the next best diagnostic investigation

    Research recommendation
    Published
    25 October 2019

  3. What is the prognostic value of different risk stratification methods for people with locally advanced prostate cancer?

    Recommendation ID NG131/7 Question What is the prognostic value of different risk stratification methods for people with locally advanced

    Research recommendation
    Published
    25 October 2019

  4. Apart from culture, what other diagnostic tests or combinations of tests are effective inestablishing an accurate diagnosis of active respiratory TB in children and young people withsuspected active TB?

    Recommendation ID NG33/2 Question Apart from culture, what other diagnostic tests or combinations of tests are effective inestablishing

    Research recommendation
    Published
    8 November 2019

  5. What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate cancer?

    Recommendation ID NG131/3 Question What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate

    Research recommendation
    Published
    25 October 2019

  6. Primary care testing: Diagnostic accuracy studies of tests accessible to primary care should be carried out for a given cancer in symptomatic people. Priority areas for research should include tests for people with cough, non-visible haematuria, suspected prostate cancer, suspected pancreatic cancer, suspected cancer in childhood and young people and other suspected rare cancers. Outcomes of interest are the performance characteristics of the test, particularly sensitivity, specificity and positive and negative predictive values.

    Recommendation ID NG12/02 Question Primary care testing: Diagnostic accuracy studies of tests accessible to primary care should be carried

    Research recommendation
    Published
    7 January 2022

  7. Diagnostic investigations to predict treatment outcomes:- What is the prognostic value of the Hevylite assay and ratio compared with other prognostic factors and tests, including the serum-free light-chain assay and fluorescence in-situ hybridisation (FISH), in people with newly diagnosed myeloma who are starting treatment?

    Recommendation ID NG35/1 Question Diagnostic investigations to predict treatment outcomes:- What is the prognostic value of the Hevylite

    Research recommendation
    Published
    5 April 2016

  8. What is the effect of dietary interventions or dietary changes on acne?

    Recommendation ID NG198/3 Question What is the effect of dietary interventions or dietary changes on acne? Any explanatory notes(if

    Research recommendation
    Published
    3 May 2024

  9. Risk prediction tool for second seizure: Development of a risk prediction tool for second seizures in people with a single seizure, and an external validation of a risk prediction tool to detect the probability of a second seizure in people with a single seizure at baseline.

    Recommendation ID NG217/09 Question Risk prediction tool for second seizure: Development of a risk prediction tool for second seizures

    Research recommendation
    Published
    11 May 2022

  10. Risk prediction tool for all-cause epilepsy-related death: Development of a risk prediction tool to detect all-cause mortality including sudden unexpected death in epilepsy (SUDEP) in people with epilepsy or those who have had a single seizure, and an external validation of a risk prediction tool to detect the probability of epilepsy-related death.

    Recommendation ID NG217/03 Question Risk prediction tool for all-cause epilepsy-related death: Development of a risk prediction tool to

    Research recommendation
    Published
    11 May 2022

  11. What is the clinical effectiveness of maggot debridement therapy in the debridement of diabetic foot ulcers?

    Recommendation ID NG19/10 Question What is the clinical effectiveness of maggot debridement therapy in the debridement of diabetic foot

    Research recommendation
    Published
    18 November 2019

  12. What is the clinical effectiveness of negative pressure wound therapy in the treatment of diabetic foot ulcers?

    Recommendation ID NG19/9 Question What is the clinical effectiveness of negative pressure wound therapy in the treatment of diabetic foot

    Research recommendation
    Published
    18 November 2019

  13. What is the clinical effectiveness of different dressing types in treating diabetic foot problems?

    Recommendation ID NG19/5 Question What is the clinical effectiveness of different dressing types in treating diabetic foot problems?

    Research recommendation
    Published
    15 November 2019

  14. Diabetic ulcer dressings:- What is the clinical effectiveness of different dressing types in treating diabetic foot problems?

    Recommendation ID NG19/5 Question Diabetic ulcer dressings:- What is the clinical effectiveness of different dressing types in treating

    Research recommendation
    Published
    12 October 2015

  15. Diagnosing asthma in adults (aged 17 and over):- What is the clinical and cost effectiveness of using an indirect bronchial challenge test with mannitol to diagnose asthma in adults (aged 17 and over)?

    Recommendation ID NG80/2 Question Diagnosing asthma in adults (aged 17 and over):- What is the clinical and cost effectiveness of using

    Research recommendation
    Published
    18 October 2018